Changes in glycosylated haemoglobin and treatment outcomes in patients with tuberculosis in Iran: A cohort study

Journal of Diabetes and Metabolic Disorders

Volumn 13, Issue 1, 2014, Pages

  Tabarsi, Payam ^a   Baghaei, Parvaneh ^a   Marjani, Majid ^a   Vollmer, William M ^b   Masjedi, Mohammad Reza ^c   Harries, Anthony D ^d,e  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b CENTER FOR HEALTH RESEARCH   (United States)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Glycosylated haemoglobin (HbA1c); Outcome; Temporary hyperglycemia; Tuberculosis

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE DURATION; FASTING BLOOD GLUCOSE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PROSPECTIVE STUDY; SMOKING; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

EID: 84988838321     PISSN: None     EISSN: 22516581     Source Type: Journal    
DOI: 10.1186/s40200-014-0123-0     Document Type: Article

References (25)

1. Jeon CY, Murray MB: Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med 2008, 5(7):e152
2. Stevenson CR, Critchley JA, Forouhi NG, Roglic G, Williams BG, Dye C, Unwin NC: Diabetes and the risk of tuberculosis: a neglected threat to public health Chron Illn 2007, 3:228-245
3. Harries AD, Satyanarayana S, Kumar AMV, Nagaraja SB, Isaakidis P, Malhotra S, Achanta S, Naik B, Wilson N, Zachariah R, Lonnroth K, Kapur A: Epidemiology and interaction of diabetes mellitus and tuberculosis and challenges for care: a review. Public Health Action 2013, 3(Suppl 1):S3 S9
4. Baker MA, Harries AD, Jeon CY, Hart JE, Kapur A, Lonnroth K, Ottmani SE, Goonesekera SD, Murray MB: The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med 2011, 9:81
5. Haghdoost AA, Rezazadeh-Kermani M, Sadghirad B, Baradaran HR: Prevalence of type 2 diabetes in the Islamic Republic of Iran: systematic review and meta-analysis. East Mediterr Health J 2009, 15(3):591 599. Review
6. World Health Organization, International Union against Tuberculosis and Lung Disease: Collaborative Framework for Care and Control of Tuberculosis and Diabetes, WHO/HTM/TB/2011.15. Geneva, Switzerland: WHO; 2011
7. Singh MM, Biswas SK, Shah A: Impaired glucose tolerance in active pulmonary tuberculosis. Ind J Tuberc 1984, 31:118 121
8. Oluboyo PO, Erasmus RT: The significance of glucose intolerance in pulmonary tuberculosis. Tubercle 1990, 71:135 138
9. World Health Organization: Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus; Abbreviated Report of a WHO Consultation. Geneva, Switzerland: WHO; 2011
10. World Health Organization: Treatment of Tuberculosis: Guidelines for National Programmes, WHO/CDS/TB/2010.313. 3rd edition. Geneva: World Health Organization; 2010
11. World Health Organization, International Union against Tuberculosis and Lung Disease: Provisional Collaborative Framework for Care and Control of Tuberculosis and Diabetes, WHO/HTM/TB/2011.15. Geneva, Switzerland: WHO; 2011 [http://whqlibdoc.who.int//publication/2011/9789241502252_eng.pdf] Accessed August 2013
12. Jawad F, Shera AS, Memon R, Ansari G: Glucose intolerance in pulmonary tuberculosis. J Pak Med Assoc 1995, 45:237 238
13. Adepoyibi T, Weigl B, Greb H, Neogi T, McGuire H: New screening technologies for type 2 diabetes mellitus appropriate for use in tuberculosis patients. Public Health Action 2013, 3(Suppl 1):10 17
14. Joint Formulary Committee, British National Formulary, British Medical Association, Royal Pharmaceutical Society of Great Britain: British National Formulary. Volume 56. London: BMJ and RPS; 2008
15. Chang JT, Dou HY, Yen CL, Wu YH, Huang RM, Lin HJ, Su IJ, Shieh CC: Effect of type 2 diabetes mellitus on the clinical severity and treatment outcome in patients with pulmonary tuberculosis: a potential role in the emergence of multidrug-resistance. J Formos Med Assoc 2011, 11:372 381
16. Fielder JF, Chaulk CP, Dalvi M, Gachuhi R, Comstock GW, Sterling TR: A high tuberculosis case-fatality rate in a setting of effective tuberculosis control: implications for acceptable treatment success rates. Int J Tuberc Lung Dis 2002, 6:1114 1117
17. Oursler KK, Moore RD, Bishai WR, Harrington SM, Pope DS, Chaisson RE: Survival of patients with pulmonary tuberculosis: clinical and molecular epidemiologic factors. Clin Infect Dis 2002, 34:752 759
18. Alisjahbana B, Sahiratmadja E, Nelwan EJ, Purwa AM, Ahmad Y, Ottenhoff THM, Nelwan RHH, Parwati I, van der Meer JW, van Crevel R: The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. Clin Infect Dis 2007, 45:428 435
19. Mi F, Tan S, Liang L, Harries AD, Hinderaker SG, Lin Y, Yue W, Chen X, Liang B, Gong F, Du J: Diabetes mellitus and tuberculosis: pattern of tuberculosis, two-month smear conversion and treatment outcomes in Guangzhou, China. Trop Med Int Health 2013, 18:1379 1385
20. Ponce-De-Leon A, Garcia-Garcia MML, Garcia-Sancho MC, Gomez-Perez FJ, Valdespino-Gomez JL, Olaiz-Fernandez G, Rojas R, Ferreyra-Reyes L, Cano-Arellano B, Bobadilla M, Small PM, Sifuentes-Osornio J: Tuberculosis and diabetes in southern Mexico. Diabetes Care 2004, 27:1584 1590
21. Wang JY, Lee LN, Hsueh PR: Factors changing the manifestation of pulmonary tuberculosis. Int J Tuberc Lung Dis 2005, 9:777 783
22. Park SW, Shin JW, Kim JY, Park IW, Choi BW, Choi JC, Kim YS: The effect of diabetic control status on the clinical features of pulmonary tuberculosis. Eur J Clin Microbiol Infect Dis 2012, 31:1305 1310
23. Dooley KE, Tang T, Golub JE, Dorman SE, Cronin W: Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis. Am J Trop Med Hyg 2009, 80:634 639
24. Khanna A, Lohya S, Sharath BN, Harries AD: Characteristics and treatment response in patients with tuberculosis and diabetes mellitus in New Delhi. India Public Health Action 2013, 3(Suppl 1):48 50
25. Jeon CY, Murray MB, Baker MA: Managing tuberculosis in patients with diabetes mellitus: why we care and what we know. Expert Rev Anti-Infect Ther 2012, 10:863 868